Axol Bioscience cardiomyocytes are derived from human iPSCs.
Human iPSC-Derived Ventricular Cardiomyocyte Kit (Male)
$1,359.00
Product code:
Description
Human iPSC-Derived Ventricular Cardiomyocyte Kit (Male)
Human iPSC-Derived Ventricular Cardiomyocyte Kit contains the optimal system of cells, tailored culture medium and optimized coating solution for maximal cell viability and growth.
Product Specification
| Starting material | Fibroblasts |
| Donor gender | Male |
| Donor age at sampling | 74 yrs |
| Karyotype | Normal |
| Reprogramming method | Episomal vector |
| Induction method | Monolayer & fully defined medium |
| Genetic modification | None |
| Kit components | 1 vial of Ventricular Cardiomyocytes (1 million cells), 1 bottle of Cardiomyocyte Maintenance Medium (500 mL) and 1 vial of Fibronectin Coating Solution (1 mL) |
| Growth properties | Adherent |
| Disease information | Healthy |
| Shipping conditions | Dry ice |
| Storage conditions | vapour phase nitrogen |
References
FAQS
Do you have any questions?
1. At the resuspension step, using P1000 and 1ml of plating medium to pipette up and down at least 5 times gently against the falcon tube which would partially disintegrate the aggregates; 2. In the counting step do not count the large aggregates and seed the culture vessel at a density of 50,000 cells/cm2 as instructed by the protocol; 3. The day after plating (Day 1), change Plating Medium to Cardiomocyte Maintenance Medium which would remove debris and cells that didn’t attach (including large aggregates). 4. Using the recommended seeding density we have achieved over 70% confluence culture after plating.
No, because the extra freeze/thaw cycle would effect the viability of the cells.
